Moneycontrol PRO
HomeNewsCipla
Jump to
  • Pharma: Is the pandemic investment template about to play out?

    The return of the flu season in India and the US, and COVID-19 in China sparked more investor interest in the sector.

  • Neutral Cipla; target of Rs 1180: Motilal Oswal

    Motilal Oswal recommended Neutral rating on Cipla with a target price of Rs 1180 in its research report dated December 15, 2022.

  • Hold Cipla; target of Rs 1210: Sharekhan

    Sharekhan recommended Hold rating on Cipla with a target price of Rs 1210 in its research report dated December 14, 2022.

  • Buy Cipla; target of Rs 1300: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated November 06, 2022.

  • Neutral Cipla; target of Rs 1180: Motilal Oswal

    Motilal Oswal recommended Neutral rating on Cipla with a target price of Rs 1180 in its research report dated November 04, 2022.

  • Buy Cipla; target of Rs 1360: Sharekhan

    Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1360 in its research report dated November 04, 2022.

  • Buy Cipla; target of Rs 1350: ICICI Direct

    ICICI Direct is bullish on Cipla recommended buy rating on the stock with a target price of Rs 1350 in its research report dated November 07, 2022.

  • Buy Cipla; target of Rs 1225: Sharekhan

    Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1225 in its research report dated September 09, 2022.

  • Neutral Cipla; target of Rs 950: Motilal Oswal

    Motilal Oswal recommended Neutral rating on Cipla with a target price of Rs 950 in its research report dated August 18, 2022.

  • Hold Cipla; target of Rs 1080: Arihant Capital

    Arihant Capital recommended hold rating on Cipla with a target price of Rs 1080 in its research report dated August 01, 2022.

  • Buy Cipla; target of Rs 1110: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1110 in its research report dated August 01, 2022.

  • Cipla: Watch out for respiratory and Peptide pipelines

    Cipla is building its Peptide pipeline with the recently launched Lanreotide injection, which has been well received

  • Buy Cipla; target of Rs 1135: ICICI Direct

    ICICI Direct is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1135 in its research report dated July 30, 2022.

  • Buy Cipla; target of Rs 1150: Sharekhan

    Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1150 in its research report dated July 29, 2022.

  • Buy Cipla; target of Rs 1095: ICICI Direct

    ICICI Direct is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1095 in its research report dated May 11, 2022.

  • Neutral Cipla; target of Rs 880: Motilal Oswal

    Motilal Oswal recommended Neutral rating on Cipla with a target price of Rs 880 in its research report dated May 11, 2022.

  • Buy Cipla; target of Rs 1085: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Cipla recommended buy rating on the stock with a target price of Rs 1085 in its research report dated May 11, 2022.

  • Buy Cipla: target of Rs 1150: Sharekhan

    Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1150 in its research report dated May 10, 2022.

  • Cipla: Targets for US complex generics on track

    Cipla is looking at launching inhalation product Advair in the second half of FY23

  • Buy Cipla: target of Rs 1150: Sharekhan

    Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1150 in its research report dated March 31, 2022.

  • Accumulate Cipla; target of Rs 998: KR Choksey

    KR Choksey recommended accumulate rating on Cipla with a target price of Rs 998 in its research report dated January 28, 2022.

  • Buy Cipla; target of Rs 1100: ICICI Direct

    ICICI Direct is bullish on Cipla recommended buy rating on the stock with a target price of Rs 1100 in its research report dated January 26, 2022.

  • Buy Cipla: target of Rs 1150: Sharekhan

    Sharekhan is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1150 in its research report dated October 26, 2021.

  • Cipla: Focus shifts to FY23 launches

    In the US market, while the Albuterol opportunity is stabilising for Cipla, traction for Arformoterol and the high-value product launch calendar in H2 FY23 is a key watch

  • Buy Cipla; target of Rs 1205: ICICI Direct

    ICICI Direct is bullish on Cipla has recommended buy rating on the stock with a target price of Rs 1205 in its research report dated August 06, 2021.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347